EFFECTS OF ADVANCED HEART FAILURE TREATMENT ON MORTALITY IN PATIENTS WITH A SYSTEMIC RIGHT VENTRICLE

Patients with a systemic right ventricle are prone to develop heart failure. Beneficial effects of ACE-inhibition, angiotensin- or betareceptor blockade (advanced heart failure treatment, AHFT) are well established for patients with heart failure due to systemic left ventricular dysfunction, however